Jointly sponsored by the Duke University School of Medicine and the American Academy of Clinical Psychiatrists.

Learning Objectives
At the conclusion of this activity, participants should be able to:

    •   Recognize overlapping symptoms and devise an approach to address the individual patient’s comorbidities
    •   Demonstrate a working knowledge of medication combinations and adjunctive therapies with the best evidence of efficacy for treatment-resistant symptoms
    •   Counsel patients on the links between psychiatric and metabolic conditions.

Who Should Attend
This activity is designed for general and geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers and other mental health professionals interested in treating patients with mood and anxiety disorders, psychotic disorders, cognitive disorders, and substance-related disorders to remission with measurement-based care.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Duke University School of Medicine and the American Academy of Clinical Psychiatrists. . The Duke University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Duke University School of Medicine designates this educational activity for a maximum of 18 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts AMA PRA Category 1 Credit(s)^TM from organizations accredited by the ACCME.

Nurse Practitioners
AANP accepts AMA PRA Category 1 Credit(s)^TM from organizations accredited by the ACCME.

Disclosure
The Duke University School of Medicine adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

Resolution of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine will implement mechanisms, prior to the planning and implementationof this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Disclaimer
The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.